Clinical trials
Completed Phase 1 Neuromuscular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2012 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cabaletta Bio | 1 |
| Edgewise Therapeutics, Inc. | 1 |
| Genethon | 1 |
| Hanyang University Seoul Hospital | 1 |
| Johns Hopkins University | 1 |
| PepGen Inc | 1 |
| ResMed | 1 |
| University of Ioannina | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromuscular Diseases | 8 |
| Muscular Diseases | 4 |
| Musculoskeletal Diseases | 4 |
| Nervous System Diseases | 3 |
| Genetic Diseases, Inborn | 2 |
| Muscular Disorders, Atrophic | 2 |
| Muscular Dystrophies | 2 |
| Neurodegenerative Diseases | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.